Brandes Investment Partners, LP Gilead Sciences, Inc. Transaction History

Brandes Investment Partners, LP

$8.37 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 10, 2022	SELL	$57.92 - $72.58 $3.79 Million - $4.75 Million	-65,436 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$64.88 - $73.64 $45,610 - $51,768	703 Added 1.09%	65,436 $4.75 Million
Q3 2021 Nov 12, 2021	BUY	$67.69 - $73.03 $485,743 - $524,063	7,176 Added 12.47%	64,733 $4.52 Million
Q2 2021 Aug 11, 2021	BUY	$63.47 - $69.35 $1.69 Million - $1.85 Million	26,633 Added 86.12%	57,557 $3.96 Million
Q1 2021 May 14, 2021	BUY	$60.0 - $68.46 $465,900 - $531,591	7,765 Added 33.53%	30,924 $2.03 Million
Q4 2020 Feb 11, 2021	BUY	$56.65 - $64.55 $77,044 - $87,788	1,360 Added 6.24%	23,159 $1.31 Million
Q3 2020 Nov 12, 2020	SELL	$62.1 - $78.08 $492,453 - $619,174	-7,930 Reduced 26.67%	21,799 $1.38 Million
Q2 2020 Aug 12, 2020	SELL	$72.34 - $84.0 $2.86 Million - $3.32 Million	-39,478 Reduced 57.04%	29,729 $2.29 Million
Q1 2020 May 13, 2020	SELL	$62.63 - $80.22 $638,074 - $817,281	-10,188 Reduced 12.83%	69,207 $5.17 Million
Q4 2019 Feb 13, 2020	SELL	$61.62 - $67.78 $28,345 - $31,178	-460 Reduced 0.58%	79,395 $5.16 Million
Q3 2019 Nov 13, 2019	SELL	$62.51 - $69.0 $209,095 - $230,805	-3,345 Reduced 4.02%	79,855 $5.06 Million
Q2 2019 Aug 13, 2019	SELL	$61.87 - $69.38 $589,126 - $660,636	-9,522 Reduced 10.27%	83,200 $5.62 Million
Q1 2019 May 10, 2019	BUY	$62.53 - $70.05 $560,643 - $628,068	8,966 Added 10.7%	92,722 $6.03 Million
Q4 2018 Feb 11, 2019	BUY	$60.54 - $79.0 $786,111 - $1.03 Million	12,985 Added 18.35%	83,756 $5.24 Million
Q3 2018 Nov 09, 2018	BUY	$71.28 - $78.92 $632,538 - $700,336	8,874 Added 14.34%	70,771 $5.46 Million
Q2 2018 Aug 13, 2018	BUY	$64.88 - $75.68 $53,461 - $62,360	824 Added 1.35%	61,897 $4.38 Million
Q1 2018 May 15, 2018	SELL	$72.84 - $88.8 $344,023 - $419,402	-4,723 Reduced 7.18%	61,073 $4.6 Million
Q4 2017 Feb 12, 2018	SELL	$71.15 - $83.52 $317,755 - $373,000	-4,466 Reduced 6.36%	65,796 $4.71 Million
Q3 2017 Nov 13, 2017	BUY	$72.11 - $85.47 $5.07 Million - $6.01 Million	70,262	70,262 $8.96 Million

Others Institutions Holding GILD

# of Institutions

1,923

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$10.9 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.4 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$6.9 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.57 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.43 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Brandes Investment Partners, LP, based on Form 13F filings with the SEC.

News

Stay updated on Brandes Investment Partners, LP with notifications on news.

Account